Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 51, 2021 - Issue 12
280
Views
6
CrossRef citations to date
0
Altmetric
General Xenobiochemistry

In silico prediction of volume of distribution of drugs in man using conformal prediction performs on par with animal data-based models

ORCID Icon, , , & ORCID Icon
Pages 1366-1371 | Received 26 Sep 2021, Accepted 23 Nov 2021, Published online: 08 Dec 2021

References

  • Ahlberg E, Spjuth O, Hasselgren C, Carlsson L. 2015. Interpretation of conformal prediction classification models. In: Gammerman A, Vovk V, Papadopoulos H, editors. Statistical learning and data sciences. Switzerland, Cham: Lecture Notes in Computer Science, Springer International Publishing; 9047, p. 323–334.
  • Alvarsson J, Arvidsson McShane S, Norinder U, Spjuth O. 2021. Predicting with confidence: using conformal prediction in drug discovery. J Pharm Sci. 110(1):42–49.
  • Alvarsson J, Eklund M, Andersson C, Carlsson L, Spjuth O, Wikberg JE. 2014. Benchmarking study of parameter variation when using signature fingerprints together with support vector machines. J Chem Inf Model. 54(11):3211–3217.
  • Aros Bio AB. 2021. https://arosbio.com/cpsign/docs/latest/.
  • Carlsson L, Eklund M, Norinder U. 2014. Aggregated conformal prediction. IFIP International Conference on Artificial Intelligence Applications and Innovations. Springer, Berlin, Heidelberg.
  • Chang CC, Lin CJ. 2011. LIBSVM: A library for support vector machines. ACM Trans Intell Syst Technol. 2(3):1–27.
  • Fagerholm U, Spjuth O, Hellberg S. 2021. Comparison between lab variability and in silico prediction errors for the unbound fraction of drugs in human plasma. Xenobiot. 51:1095–1100.
  • Fan RE, Chang KW, Hsieh CJ, Wang XR, Lin CJ. 2008. LIBLINEAR: a library for large linear classification. J Machine Learning Res. 9:1871–1874.
  • Faulon JL, Churchwell CJ, Visco DP. 2003. The signature molecular descriptor. 2. Enumerating molecules from their extended valence sequences. J Chem Inf Comput Sci. 43(3):721–734.
  • Guo C, Pleiss G, Sun Y, Weinberger KQ. 2017. On calibration of modern neural networks. Proceedings of the 34th International Conference on Machine Learning, Sydney, Australia, PMLR 70. p. 1–14.
  • Hearst A, Dumais ST, Osuna E, Platt J, Scholkop B. 1998. Support vector machines. IEEE Intell Syst Their Appl. 13(4):18–28.
  • Lampa S, Alvarsson J, Arvidsson Mc Shane S, Berg A, Ahlberg E, Spjuth O. 2018. Predicting off-target binding profiles with confidence using conformal prediction. Front Pharmacol. 9(1256):1256.
  • Lapins M, Arvidsson S, Lampa S, Berg A, Schaal W, Alvarsson J, Spjuth O. 2018. A confidence predictor for logd using conformal regression and a support-vector machine. J Cheminf. 10:17.
  • Lombardo F, Berellini G, Obach RS. 2018. Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 1352 drug compounds. Drug Metab Dispos. 46(11):1466–1477.
  • Lombardo F, Obach RS, Dicapua FM, Bakken GA, Lu J, Potter DM, Gao F, Miller MD, Zhang Y. 2006. A hybrid mixture discriminant analysis-random forest computational Model for the prediction of volume of distribution of drugs in human. J Med Chem. 49(7):2262–2267.
  • Miljković F, Martinsson A, Obrezanova O, Williamson B, Johnson M, Sykes A. 2021. Machine learning models for human in vivo pharmacokinetic parameters with in-house validation. Mol Pharmaceut. [online ahead of print].
  • Norinder U, Carlsson L, Boyer S, Eklund M. 2014. Introducing conformal prediction in predictive modeling. A transparent and flexible alternative to applicability domain determination. J Chem Inf Model. 54(6):1596–1603.
  • Norinder U, Carlsson L, Boyer S, Eklund M. 2015. Introducing conformal prediction in predictive modeling for regulatory purposes. A transparent and flexible alternative to applicability domain determination. Regul Toxicol Pharmacol. 71(2):279–284.
  • Norinder U, Rybacka A, Andersson PL. 2016. Conformal prediction to define applicability domain - A case study on predicting ER and AR binding. SAR QSAR Environ Res. 27(4):303–316.
  • Obach R, Lombardo F, Waters NJ. 2008. Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug Metab Dispos. 36(7):1385–1405.
  • Petersson C, Papasouliotis O, Lecomte M, Badolo L, Dolgos H. 2020. Prediction of volume of distribution in humans: analysis of eight methods and their application in drug discovery. Xenobiotica. 50(3):270–279.
  • Shimizu H, Yoshida K, Nakada T, Kojima K, Ogasawara A, Nakamaru Y, Yamazaki H. 2019. Prediction of human distribution volumes of compounds in various elimination phases using physiologically based pharmacokinetic modeling and experimental pharmacokinetics in animals. Drug Metab Dispos. 47(2):114–123.
  • Sohlenius-Sternbeck A-K, Afzelius L, Prusis P, Neelissen J, Hoogstraate J, Johansson J, Floby E, Bengtsson A, Gissberg O, Sternbeck J, et al. 2010. Evaluation of the human prediction of clearance from hepatocyte and microsome intrinsic clearance for 52 drug compounds. Xenobiotica. 40(9):637–649.
  • Svensson F, Norinder U, Bender A. 2017. Modelling compound cytotoxicity using conformal prediction and pubchem hts data. Toxicol Res (Camb)). 6(1):73–80.
  • Vovk V, Gammerman A, Shafer G. 2005. Algorithmic learning in a random world. Switzerland: Springer Science & Business Media.
  • Watanabe R, Esaki T, Kawashima H, Natsume-Kitatani Y, Nagao C, Ohashi R, Mizuguchi K. 2018. Predicting fraction unbound in human plasma from chemical structure: Improved accuracy in the low value ranges. Mol Pharm. 15(11):5302–5311.
  • Willighagen EL, Mayfield JW, Alvarsson J, Berg A, Carlsson L, Jeliazkova N, Kuhn S, Pluskal T, Rojas-Cherto M, Spjuth O, et al. 2017. The Chemistry Development Kit (CDK) v2.0: atom typing, depiction, molecular formulas, and substructure searching. J Cheminf. 9:1–19.
  • Yamagata T, Zanelli U, Gallemann D, Perrin D, Dolgos H, Petersson C. 2017. Comparison of methods for the prediction of human clearance from hepatocyte intrinsic clearance for a set of reference compounds and an external evaluation set. Xenobiotica. 47(9):741–751.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.